Table 2A.
Observed objective response rate (ORR) by tumor histology subtype
| N | ORR (%) | OR (95% CI) vs. PUC | p value | |
|---|---|---|---|---|
| PUC | 278 | 28% | ||
| VUC | 117 | 29% | 1.03 (0.64 - 1.66) | 0.90 |
| Squamous | 50 | 28% | 0.98 (0.50 - 1.91) | 0.95 |
| Micropapillary | 25 | 28% | 0.98 (0.39 - 2.44) | 0.97 |
| Sarcomatoid | 16 | 38% | 1.51 (0.53 – 4.30) | 0.44 |
| Plasmacytoid | 12 | 17% | 0.50 (0.11 - 2.35) | 0.38 |
| Adenocarcinoma | 10 | 20% | 0.63 (0.13 – 3.03) | 0.56 |
| NE | 8 | 25% | 0.84 (0.17 – 4.25) | 0.83 |
| OR (95% CI) vs. VUC w/o NE | ||||
| VUC without NE | 109 | 29% | ||
| NE | 8 | 25% | 0.80 (0.15 – 4.19) | 0.79 |
NE: neuroendocrine, PUC, pure urothelial carcinoma; VUC, variant urothelial carcinoma